FNY Partners Fund’s Cellectis CLLS Stock Holding History

FNY Partners Fund’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-110	Closed	-$3K	–	458
2017 Q3	$3K	Buy	+110	New	+$2.85K	﹤0.01%	477

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

FNY Partners Fund's CLLS Position: Q3 2017 in Review

FNY Partners Fund sold out of Cellectis (CLLS) in Q3 2017, closing a stake of 1,000 shares — an estimated $25.9K sold.

FNY Partners Fund first reported a position in CLLS in Q4 2016 and held it in 3 quarters. The position peaked at $36K in Q1 2017. 42 funds tracked by Wall St. Rank hold CLLS as of Q3 2017.

FNY Partners Fund reported no remaining Cellectis position as of Q3 2017 after selling out during the quarter.
FNY Partners Fund sold 1,000 Cellectis shares in Q3 2017, an estimated $25.9K.
FNY Partners Fund first reported a position in Cellectis in Q4 2016 and held it in 3 quarters.
FNY Partners Fund's Cellectis position peaked at $36K in Q1 2017.
42 funds tracked by Wall St. Rank held Cellectis as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.